Recent News

• 06.06.2025 - TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 06.06.2025 - TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 06.06.2025 - TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 06.05.2025 - 2025 Jefferies Global Healthcare Conference
• 06.05.2025 - 2025 Jefferies Global Healthcare Conference
• 06.03.2025 - TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
• 06.03.2025 - TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
• 06.03.2025 - TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
• 06.02.2025 - TELA Bio Appoints Jeffrey Blizard as President
• 06.02.2025 - TELA Bio Appoints Jeffrey Blizard as President

Recent Filings

• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - EX-99.1 EX-99.1
• 06.02.2025 - 8-K Current report
• 05.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.30.2025 - 8-K Current report
• 05.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.30.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.30.2025 - 4 Statement of changes in beneficial ownership of securities